PEDIATRICS Vol. 68 No. 5 November 1981, pp. 638-643
This Article
Right arrow Full Text (PDF)
Right arrow P3Rs: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when P3Rs are posted
Right arrow Alert me if a correction is posted
Services
Right arrow E-mail this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My File Cabinet
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by MacArthur, B. A.
Right arrow Articles by Elkins, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by MacArthur, B. A.
Right arrow Articles by Elkins, J.

Cognitive and Psychosocial Development of 4-Year-Old Children Whose Mothers Were Treated Antenatally with Betamethasone

B. A. MacArthur MA, PhD1, R. N. Howie MB, ChB, FRACP1, J. A. Dezoete BA,NZRGON,NZRM1, and J. Elkins BSc,BEd,PhD1

1 Departments of Education and Paediatrics, University of Auckland, Auckland, New Zealand, and Schonell Educational Research Centre, University of Queensland, Brisbane, Australia

The present study was part of a larger study investigating the long-term development of children of mothers included in a controlled trial of betamethasone therapy in preterm labor; the purpose was to determine whether there are any benefits or hazards of treatment detectable up to the seventh year of life. The first 318 children of mothers included in the trial because of spontaneous premature labor were selected for study. Of 305 survivors, 258 (84.6%) were included in this phase of the study. Detailed tests of psychological development, together with assessments of psychosocial background, were made during the fifth year. Of the 258 children 144 were in the betamethasone group and 114 were control patients. Despite a heavy weighting of the betamethasone group with more prematurely delivered infants and more boys (resulting from improved perinatal survival of these children associated with betamethasone therapy), no significant differences emerged between the groups in measures of outcome. It was concluded that betamethasone therapy, under the conditions of the original trial, was not hazardous to cognitive development as measured in this study.

Submitted on February 17, 1981
Accepted on July 9, 1981




This article has been cited by other articles:


Home page
 Reproductive SciencesHome page
P. Kumar, R. Seshadri, and W. A. Grobman
Neurodevelopmental Outcome of Very Low Birth Weight Infants After Multiple Courses of Antenatal Corticosteroids
Reproductive Sciences, October 1, 2004; 11(7): 483 - 487.
[Abstract] [PDF]

Home page
 PediatricsHome page
S. R. Dalziel, A. Liang, V. Parag, A. Rodgers, and J. E. Harding
Blood Pressure at 6 Years of Age After Prenatal Exposure to Betamethasone: Follow-up Results of a Randomized, Controlled Trial
Pediatrics, September 1, 2004; 114(3): e373 - e377.
[Abstract] [Full Text] [PDF]

Home page
 Obstet GynecolHome page
A. H. SCHAAP, H. WOLF, H. W. BRUINSE, H. S.-D. HAAS, I. VAN ERTBRUGGEN, and P. E. TREFFERS
Effects of Antenatal Corticosteroid Administration on Mortality and Long-term Morbidity in Early Preterm, Growth-Restricted Infants
Obstet. Gynecol., June 1, 2001; 97(6): 954 - 960.
[Abstract] [Full Text] [PDF]

Home page
 PediatricsHome page
L. W. Doyle, G. W. Ford, A. L. Rickards, E. A. Kelly, N. M. Davis, C. Callanan, and A. Olinsky
Antenatal Corticosteroids and Outcome at 14 Years of Age in Children With Birth Weight Less Than 1501 Grams
Pediatrics, July 1, 2000; 106(1): 2e - 2.
[Abstract] [Full Text]